zidovudine

Generic: zidovudine

Labeler: aurobindo pharma limited
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name zidovudine
Generic Name zidovudine
Labeler aurobindo pharma limited
Dosage Form TABLET, FILM COATED
Routes
ORAL
Active Ingredients

zidovudine 300 mg/1

Manufacturer
Aurobindo Pharma Limited

Identifiers & Regulatory

Product NDC 65862-024
Product ID 65862-024_0f90ebc4-1e78-420b-a2cb-0dc715bdb853
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA077267
Listing Expiration 2026-12-31
Marketing Start 2005-09-19

Pharmacologic Class

Established (EPC)
human immunodeficiency virus nucleoside analog reverse transcriptase inhibitor [epc]
Mechanism of Action
nucleoside reverse transcriptase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 65862024
Hyphenated Format 65862-024

Supplemental Identifiers

RxCUI
199663
UNII
4B9XT59T7S
NUI
N0000175462 N0000009947

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name zidovudine (source: ndc)
Generic Name zidovudine (source: ndc)
Application Number ANDA077267 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 300 mg/1
source: ndc
Packaging
  • 6 BLISTER PACK in 1 CARTON (65862-024-10) / 10 TABLET, FILM COATED in 1 BLISTER PACK
  • 60 TABLET, FILM COATED in 1 BOTTLE (65862-024-60)
source: ndc

Packages (2)

Ingredients (1)

zidovudine (300 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "0f90ebc4-1e78-420b-a2cb-0dc715bdb853", "openfda": {"nui": ["N0000175462", "N0000009947"], "unii": ["4B9XT59T7S"], "rxcui": ["199663"], "spl_set_id": ["e7c8ddef-005d-4f1c-8c1a-ea84044ab4d4"], "pharm_class_epc": ["Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"], "pharm_class_moa": ["Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "manufacturer_name": ["Aurobindo Pharma Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "6 BLISTER PACK in 1 CARTON (65862-024-10)  / 10 TABLET, FILM COATED in 1 BLISTER PACK", "package_ndc": "65862-024-10", "marketing_start_date": "20050919"}, {"sample": false, "description": "60 TABLET, FILM COATED in 1 BOTTLE (65862-024-60)", "package_ndc": "65862-024-60", "marketing_start_date": "20050919"}], "brand_name": "Zidovudine", "product_id": "65862-024_0f90ebc4-1e78-420b-a2cb-0dc715bdb853", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "product_ndc": "65862-024", "generic_name": "Zidovudine", "labeler_name": "Aurobindo Pharma Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Zidovudine", "active_ingredients": [{"name": "ZIDOVUDINE", "strength": "300 mg/1"}], "application_number": "ANDA077267", "marketing_category": "ANDA", "marketing_start_date": "20050919", "listing_expiration_date": "20261231"}